Prospective cross-over study on the interaction between furosemide and sevelamer in hemodialysis patients.
Completed
- Conditions
- 10038430dialyse patiententerminal renal failure
- Registration Number
- NL-OMON33060
- Lead Sponsor
- Canisius Wilhelmina Ziekenhuis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 6
Inclusion Criteria
age 18-90 years
end stage renal disease, hemodialysis since >=3 months
diuresis> 100ml/d with furosemide
furosemide dosage >=500mg a day
patient can collect 24h urine
Exclusion Criteria
sevelamer is contraindicated
already using sevelamer
cardiovascular instability
clinically overhydrated
engaged in medication research within 1 month prior to inclusion
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>volume 24 hr urine<br /><br>Concentration furosemide urine.</p><br>
- Secondary Outcome Measures
Name Time Method <p>x</p><br>